table of content
Table of Contents
Global Pharmacokinetics Services Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Pharmacokinetics Services Market by Value
2.2.1 Global Pharmacokinetics Services Revenue by Type
2.2.2 Global Pharmacokinetics Services Market by Value (%)
2.3 Global Pharmacokinetics Services Market by Production
2.3.1 Global Pharmacokinetics Services Production by Type
2.3.2 Global Pharmacokinetics Services Market by Production (%)
3. The Major Driver of Pharmacokinetics Services Industry
3.1 Historical & Forecast Global Pharmacokinetics Services Demand
3.2 Largest Application for Pharmacokinetics Services (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Pharmacokinetics Services Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Pharmacokinetics Services Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Pharmacokinetics Services Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Pharmacokinetics Services Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Pharmacokinetics Services Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Pharmacokinetics Services Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Pharmacokinetics Services Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Pharmacokinetics Services Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Pharmacokinetics Services Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Pharmacokinetics Services Average Price Trend
12.1 Market Price for Each Type of Pharmacokinetics Services in US (2018-2022)
12.2 Market Price for Each Type of Pharmacokinetics Services in Europe (2018-2022)
12.3 Market Price for Each Type of Pharmacokinetics Services in China (2018-2022)
12.4 Market Price for Each Type of Pharmacokinetics Services in Japan (2018-2022)
12.5 Market Price for Each Type of Pharmacokinetics Services in India (2018-2022)
12.6 Market Price for Each Type of Pharmacokinetics Services in Korea (2018-2022)
12.7 Market Price for Each Type of Pharmacokinetics Services in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Pharmacokinetics Services Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Pharmacokinetics Services
14. Pharmacokinetics Services Competitive Landscape
14.1 Evotec AG (Germany)
14.1.1 Evotec AG (Germany) Company Profiles
14.1.2 Evotec AG (Germany) Product Introduction
14.1.3 Evotec AG (Germany) Pharmacokinetics Services Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Pacific BioLabs (US)
14.2.1 Pacific BioLabs (US) Company Profiles
14.2.2 Pacific BioLabs (US) Product Introduction
14.2.3 Pacific BioLabs (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 GVK Biosciences Private Limited (India)
14.3.1 GVK Biosciences Private Limited (India) Company Profiles
14.3.2 GVK Biosciences Private Limited (India) Product Introduction
14.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Shanghai Medicilon Inc. (China)
14.4.1 Shanghai Medicilon Inc. (China) Company Profiles
14.4.2 Shanghai Medicilon Inc. (China) Product Introduction
14.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Pharmaceutical Product Development, LLC (US)
14.5.1 Pharmaceutical Product Development, LLC (US) Company Profiles
14.5.2 Pharmaceutical Product Development, LLC (US) Product Introduction
14.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Charles River Laboratories International, Inc. (US)
14.6.1 Charles River Laboratories International, Inc. (US) Company Profiles
14.6.2 Charles River Laboratories International, Inc. (US) Product Introduction
14.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 PAREXEL International Corporation (US)
14.7.1 PAREXEL International Corporation (US) Company Profiles
14.7.2 PAREXEL International Corporation (US) Product Introduction
14.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Eurofins Scientific, Inc. (Luxembourg)
14.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Profiles
14.8.2 Eurofins Scientific, Inc. (Luxembourg) Product Introduction
14.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Frontage Labs (US)
14.9.1 Frontage Labs (US) Company Profiles
14.9.2 Frontage Labs (US) Product Introduction
14.9.3 Frontage Labs (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 SGS SA (Switzerland)
14.10.1 SGS SA (Switzerland) Company Profiles
14.10.2 SGS SA (Switzerland) Product Introduction
14.10.3 SGS SA (Switzerland) Pharmacokinetics Services Sales, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 LGC Limited (UK)
14.12 Creative Bioarray (US)
14.13 Certara, L.P. (Germany)
15. Conclusion
16. Methodology and Data Source
